Search Results

Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.

A long-standing question across oncology is why the same cancer may be very aggressive in some patients but not in others.

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern researchers more than $34 million for cancer research and faculty recruitment, including support for programs in pancreatic cancer, lung cancer, breast cancer, and melanoma.

The high acidity of cancer cells yielded the clue that led to the development of a tool that significantly improves surgeons’ abilities to remove cancerous tissues

The March 21 decision by NCCN to include the Simmons Cancer Center among its members recognizes Simmons Cancer Center’s elite status and will deepen its collaboration with national peers at the highest levels.

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern researchers more than $27 million, including nearly $3 million for two key cancer screening programs in underserved areas.

UT Southwestern researchers have found that a protein in the body’s innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

Researchers at UT Southwestern have uncovered the means by which pediatric kidney cancer continues to grow, providing potential targets for more effective treatments in the future.

Investigators report an innovative strategy for treating advanced kidney cancer.

Molecular biologists at UT Southwestern Medical Center have identified a gene called NORAD that helps maintain the proper number of chromosomes in cells, and that when inactivated, causes the number of chromosomes in a cell to become unstable.